Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nuijten, Mark J.C.
198  Ergebnisse:
Personensuche X
?
1

Clinical and economic issues complicating cost-effectivenes..:

Nuijten, Mark J.C. ; Pronk, Marja H. ; Hutton, John...
The EuroBiotech Journal.  1 (2017)  2 - p. 132-137 , 2017
Link: https://doi.org/10.24190..
 
?
2

Health economic modeling to assess short-term costs of mate..:

Lenoir-Wijnkoop, Irene ; van der Beek, Eline M. ; Garssen, Johan..
Frontiers in Pharmacology.  6 (2015)  - p. , 2015
Link: https://doi.org/10.3389/..
 
?
3

Cost-effectiveness of prucalopride in the treatment of chro..:

Nuijten, Mark J. C. ; Dubois, Dominique J. ; Joseph, Alain.
Frontiers in Pharmacology.  6 (2015)  - p. , 2015
Link: https://doi.org/10.3389/..
 
?
4

Nutrition economic evaluation of a probiotic in the prevent..:

Lenoir-Wijnkoop, Irene ; Nuijten, Mark J. C. ; Craig, Joyce.
Frontiers in Pharmacology.  5 (2014)  - p. , 2014
Link: https://doi.org/10.3389/..
 
?
5

The economic costs of disease related malnutrition:

Freijer, Karen ; Tan, Siok Swan ; Koopmanschap, Marc A....
Clinical Nutrition.  32 (2013)  1 - p. 136-141 , 2013
Link: https://doi.org/10.1016/..
 
?
6

A cross-market cost comparison of erlotinib versus pemetrex..:

Nuijten, Mark J.C. ; de Castro Carpeño, Javier ; Chouaid, Christos...
Lung Cancer.  76 (2012)  3 - p. 465-471 , 2012
Link: https://doi.org/10.1016/..
 
?
7

The Budget Impact of Oral Nutritional Supplements for Disea..:

Freijer, Karen ; Nuijten, Mark J. C. ; Schols, Jos M. G. A.
Frontiers in Pharmacology.  3 (2012)  - p. , 2012
Link: https://doi.org/10.3389/..
 
?
8

Cost-Effectiveness of Escitalopram in Major Depressive Diso..:

Nuijten, Mark J.C. ; Brignone, Mélanie ; Marteau, Florence..
Clinical Therapeutics.  34 (2012)  6 - p. 1364-1378 , 2012
Link: https://doi.org/10.1016/..
 
?
9

Primary prevention of nephrolithiasis is cost‐effective for..:

Lotan, Yair ; Buendia Jiménez, Inmaculada ; Lenoir‐Wijnkoop, Irene...
BJU International.  110 (2012)  11c - p. , 2012
Link: https://doi.org/10.1111/..
 
?
10

A Concise Equation That Captures the Essential Elements of ..:

Nuijten, Mark J. C. ; Van Gelder, Pieter H. A. J. M.
Medical Decision Making.  31 (2011)  4 - p. 642-649 , 2011
Link: https://doi.org/10.1177/..
 
?
11

Cost-Utility Analysis: Current Methodological Issues and Fu..:

Dubois, Dominique J. ; Nuijten, Mark J. C.
Frontiers in Pharmacology.  2 (2011)  - p. , 2011
Link: https://doi.org/10.3389/..
 
?
12

Cost-effectiveness of palivizumab against respiratory syncy..:

Resch, Bernhard ; Gusenleitner, Walter ; Nuijten, Mark J.C...
Clinical Therapeutics.  30 (2008)  4 - p. 749-760 , 2008
Link: https://doi.org/10.1016/..
 
?
13

Cost Effectiveness of Palivizumab for Respiratory Syncytial..:

Nuijten, Mark J C ; Wittenberg, Wolfgang ; Lebmeier, Maximilian
PharmacoEconomics.  25 (2007)  1 - p. 55-71 , 2007
Link: https://doi.org/10.2165/..
 
?
14

Pricing matrix model: dealing with uncertainty:

Nuijten, Mark J. C.
The European Journal of Health Economics.  8 (2007)  4 - p. 333-337 , 2007
Link: https://doi.org/10.1007/..
 
?
15

Pricing matrix model: dealing with uncertainty:

Nuijten, Mark J. C.
The European Journal of Health Economics.  8 (2007)  4 - p. 333-337 , 2007
Link: https://www.jstor.org/st..
 
1-15